Drug resistance is a major cause of treatment failure in cancer patients receiving cytotoxic or targeted therapies for disseminated cancer (Dannenberg and Berns, 2010), and numerous reports have shown that TM4SF1 is positively associated with drug resistance. Here, TM4SF1 is linked to cancer.